06 Mar2024Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy ProgramAuthor By Healthufit Posted on March 6, 2024March 6, 2024Genezen Announces Strategic Process Development and Manufacturing Partnersh...